Expression of CD19 is maintained in haematological B‐cell malignancies, including DLBCL, follicular lymphoma and mantle cell lymphoma, and the majority of B‐cell malignancies express CD19 at normal‐to‐high levels [7]. This evidence concerns the gene CD19 and mantle cell lymphoma.